Publications by authors named "Garcia-Morante B"

Cranioventral pulmonary consolidation (CVPC) is a common lesion observed in the lungs of slaughtered pigs, often associated with Mycoplasma (M.) hyopneumoniae infection. There is a need to implement simple, fast, and valid CVPC scoring methods.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to create a model to understand how Mycoplasma hyopneumoniae causes respiratory disease in pigs, focusing on its effects on infection, immune response, and disease progression.
  • - Four groups of pigs were exposed to different aerosol doses of the bacteria, with secretions collected and analyzed at various time points to assess infection and immune response.
  • - Findings indicated that all pigs became infected regardless of the dose, but only high-dose exposures led to severe clinical symptoms and lung damage, demonstrating the model's potential for testing treatments and prevention strategies.
View Article and Find Full Text PDF

Gaining insight into the size and composition of national pig populations can support decisions on disease control, welfare, and environmental sustainability. However, if one needs to draw meaningful comparisons between the performance of various production systems or countries, a method for standardization is required. One approach to achieve this is by means of biomass estimation.

View Article and Find Full Text PDF
Article Synopsis
  • Erysipelas continues to significantly impact the pig industry economically, and preventing it in young pigs relies heavily on maternal immunity, which can be enhanced through strategic vaccination.
  • A study investigated the effects of two vaccination strategies (pre-farrowing vs. post-farrowing) on antibody levels in sows and their piglets, using two different tests to assess changes in immunity.
  • Results indicated that pre-farrowing vaccination led to higher antibody levels in both sows and their offspring compared to post-farrowing vaccination, with beneficial effects on piglet immunity lasting into the post-weaning period.
View Article and Find Full Text PDF
Article Synopsis
  • * Key issues include difficulties in collecting and accessing reliable data, as well as the need for standardized information to enhance decision-making effectiveness.
  • * A user-friendly and adaptable data tool is seen as essential for veterinarians, particularly independent practitioners, to monitor health conditions, visualize disease prevalence, and receive timely alerts for better disease management.
View Article and Find Full Text PDF
Article Synopsis
  • - Farmers and veterinarians in the livestock sector lack sufficient information on the prevalence and impact of contagious diseases, necessitating better risk assessment tools for disease management.
  • - The DECIDE project creates data-driven decision-support tools that provide early disease signals, diagnostic options, and control strategies while considering the effects on disease spread, economic impacts, and animal welfare.
  • - By focusing on major livestock species and incorporating stakeholder needs, cost evaluations, and advanced modeling, DECIDE aims to enhance disease surveillance and decision-making, ultimately promoting a healthier and more sustainable European food chain.
View Article and Find Full Text PDF

Background: Understanding the financial consequences of endemically prevalent pathogens within the porcine respiratory disease complex (PRDC) and the effects of interventions assists decision-making regarding disease prevention and control. The aim of this systematic review was to identify what economic studies have been carried out on infectious endemic respiratory disease in pigs, what methods are being used, and, when feasible, to identify the economic impacts of PRDC pathogens and the costs and benefits of interventions.

Results: By following the PRISMA method, a total of 58 studies were deemed eligible for the purpose of this systematic review.

View Article and Find Full Text PDF

Mycoplasma hyopneumoniae remains one of the most problematic bacterial pathogens for pig production. Despite an abundance of observational and laboratory testing capabilities for this organism, diagnostic interpretation of test results can be challenging and ambiguous. This is partly explained by the chronic nature of M.

View Article and Find Full Text PDF

Porcine parvovirosis is a common and important cause of reproductive failure in naïve dams. Even though vaccination is generally effective at preventing disease occurrence, the homology between the vaccine and challenge strains has been recently suggested to play a role in protection. Therefore, the purpose of this study was to evaluate and compare the efficacy of three currently available commercial vaccines against porcine parvovirus genotype 1 (PPV1) in an experimental model using pregnant gilts.

View Article and Find Full Text PDF

The efficacy of the combined administration of a porcine reproductive and respiratory syndrome (PRRS) modified live virus (MLV) vaccine and a porcine parvovirus 1 (PPV1) subunit vaccine in gilts was addressed in two experiments. Experiment A aimed to establish a 4-week onset of immunity (OOI). Gilts were randomly distributed in three treatment groups: non-vaccinated control animals (group 1), animals vaccinated with the combined vaccine (group 2), and a third group that consisted of animals vaccinated with the PRRS MLV vaccine alone (group 3).

View Article and Find Full Text PDF

Background: Porcine parvovirus 1 (PPV1) is widespread in commercial pig farms worldwide and has a significant impact to the swine industry. Long-lasting immunity achieved by means of vaccination is the main tool to prevent PPV1 infection and its associated clinical signs. Here we evaluated the duration of immunity (DOI) conferred by a novel subunit vaccine based on the viral protein (VP) 2 of PPV1, named ReproCyc® ParvoFLEX.

View Article and Find Full Text PDF

Background: Porcine reproductive and respiratory syndrome virus (PRRSV) and porcine parvovirus 1 (PPV1) are two common causes of reproductive failure. ReproCyc® ParvoFLEX is a novel subunit vaccine based on the protective viral protein (VP) 2 of PPV1 that has been recently licensed in the European (EU) market, whereas ReproCyc® PRRS EU is a porcine reproductive and respiratory syndrome (PRRS) modified live virus (MLV) vaccine authorized in 2015. The present work sought to evaluate the safety and compatibility of the combined administration of the abovementioned vaccines in target animals under the context of a field PRRSV (experiment A) and PPV1 (experiment B) infection.

View Article and Find Full Text PDF

Porcine parvovirus 1 (PPV1) viral protein (VP) 2 is the primary antigen responsible for inducing specific protective immunity, so it is a desirable target for development of recombinant subunit vaccines to prevent PPV1 disease. The objective of this study was to evaluate repeated doses of a novel VP2-based PPV1 subunit vaccine, namely ReproCyc® ParvoFLEX, for safety in bred pigs and in offspring under experimental settings. Therefore, the investigation of safety at all breeding stages was evaluated in four independent studies involving: pre-breeding gilts (study A), breeding-age gilts and boars (study B), early and late gestating sows and offspring (study C) and lactating sows and offspring (study D).

View Article and Find Full Text PDF

Information on the in vitro growth of pathogenic and non-pathogenic Mycoplasma hyopneumoniae (M. hyopneumoniae) strains is scarce and controversial. Despite its limitations, the colour changing units (CCU) assay is still considered the golden standard titration technique for M.

View Article and Find Full Text PDF

One of the main Mycoplasma hyopneumoniae (M. hyopneumoniae) swine experimental model objectives is to reproduce mycoplasmal pneumonia (MP). Unfortunately, experimental validated protocols to maximize the chance to successfully achieve lung lesions induced by M.

View Article and Find Full Text PDF

Immunopathological events are key for the development of enzootic pneumonia (EP), which is macroscopically observed as cranioventral pulmonary consolidation (CVPC). This study aimed to investigate the putative association between the humoral immune response against Mycoplasma hyopneumoniae (M. hyopneumoniae) and prevalence and extension of CVPC in 1) experimentally infected pigs, 2) slaughtered pigs and 3) sequentially necropsied pigs in a longitudinal study.

View Article and Find Full Text PDF

A 2-year-old female, spur-thighed tortoise (Testudo graeca) was presented with poor body condition (1/5) and weakness. Fecal analysis revealed large numbers of oxyurid-like eggs, and radiographs were compatible with gastrointestinal obstruction. Despite supportive medical treatment, the animal died.

View Article and Find Full Text PDF

The purpose of this study was to assess the effect of three different inoculation routes into mycoplasmal pneumonia (MP) in pigs challenged with Mycoplasma hyopneumoniae (M. hyopneumoniae). Thirty six-week-old M.

View Article and Find Full Text PDF

Mycoplasma hyopneumoniae is the primary aetiological agent of swine enzootic pneumonia (EP) and one of the major contributors to the porcine respiratory disease complex (PRDC). Gross lung lesions in pigs affected by EP consist of cranioventral pulmonary consolidation (CVPC), usually distributed bilaterally in the apical, intermediate, accessory and cranial parts of the diaphragmatic lobes. Several lung scoring methods are currently in place for the evaluation of CVPC.

View Article and Find Full Text PDF